These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9858889)

  • 21. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.
    Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW
    Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A phase I trial of adenoviral p53 gene therapy for non-small cell lung cancer].
    Fujiwara T; Kataoka M; Kawamata O; Tanaka N
    Nihon Geka Gakkai Zasshi; 1999 Nov; 100(11):749-55. PubMed ID: 10629843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [CNHK200-hA-a gene-viral therapeutic system and its antitumor effect on lung cancer].
    Wang WG; Xue HB; Su CQ; Cui ZF; Nie MM; Sham J; Wu MC; Qian QJ
    Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):69-72. PubMed ID: 15946541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The inhibitory effect of adenovirus-mediated p16INK4a gene transfer on the proliferation of lung cancer cell line.
    Lee JH; Lee CT; Yoo CG; Hong YK; Kim CM; Han SK; Shim YS; Carbone DP; Kim YW
    Anticancer Res; 1998; 18(5A):3257-61. PubMed ID: 9858892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
    Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
    Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced therapeutic efficacy of oncolytic herpes vector G207 against human non-small cell lung cancer--expression of an RNA-binding protein, Musashi1, as a marker for the tailored gene therapy.
    Kanai R; Eguchi K; Takahashi M; Goldman S; Okano H; Kawase T; Yazaki T
    J Gene Med; 2006 Nov; 8(11):1329-40. PubMed ID: 16955534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical study of adenoviral mediated p53 gene therapy for non-small cell lung cancer in Japan].
    Kagawa S; Fujiwara T; Tanaka N
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):193-7. PubMed ID: 12610865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement.
    Roth JA; Swisher SG; Merritt JA; Lawrence DD; Kemp BL; Carrasco CH; El-Naggar AK; Fossella FV; Glisson BS; Hong WK; Khurl FR; Kurie JM; Nesbitt JC; Pisters K; Putnam JB; Schrump DS; Shin DM; Walsh GL
    Semin Oncol; 1998 Jun; 25(3 Suppl 8):33-7. PubMed ID: 9704675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restoration of p53 function in anaplastic Wilms' tumor.
    Delatte SJ; Hazen-Martin DJ; Re GG; Kelly JR; Sutphin A; Tagge EP
    J Pediatr Surg; 2001 Jan; 36(1):43-50. PubMed ID: 11150436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic potential of recombinant adenovirus expressing p53 in hepatocellular carcinoma cell lines].
    Guo Y; Zeng Y; Wang K; Zhu X; Luo H; Zheng M; Li M; Chen J
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():43-5. PubMed ID: 11509137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenovirus-mediated tissue-targeted expression of the HSVtk gene for the treatment of breast cancer.
    Anderson LM; Swaminathan S; Zackon I; Tajuddin AK; Thimmapaya B; Weitzman SA
    Gene Ther; 1999 May; 6(5):854-64. PubMed ID: 10505111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidermal growth factor mediated DNA delivery into lung cancer cells via the epidermal growth factor receptor.
    Cristiano RJ; Roth JA
    Cancer Gene Ther; 1996; 3(1):4-10. PubMed ID: 8785711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexes.
    Densmore CL; Kleinerman ES; Gautam A; Jia SF; Xu B; Worth LL; Waldrep JC; Fung YK; T'Ang A; Knight V
    Cancer Gene Ther; 2001 Sep; 8(9):619-27. PubMed ID: 11593330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer.
    Oakley R; Phillips E; Hooper R; Wilson D; Partridge M
    Clin Cancer Res; 2002 Jun; 8(6):1984-94. PubMed ID: 12060644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adenovirus-mediated p53 gene therapy of human laryngeal cancer].
    Wang Q; Han D; Wang W
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):418-21. PubMed ID: 10920932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Construction of a RU486 inducible recombinant adenoviral vector carrying murine interleukin-12 gene and experimental treatment of colonic carcinoma].
    Chen J; Liu XS; Wang F; Xue XC; Fang GE; Su CQ; Qian QJ
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1372-6. PubMed ID: 19671324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vector.
    Rohr UP; Wulf MA; Stahn S; Heyd F; Steidl U; Fenk R; Opalka B; Pitschke G; Prisack HB; Bojar H; Haas R; Kronenwett R
    Cancer Gene Ther; 2003 Dec; 10(12):898-906. PubMed ID: 14712316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients.
    Boulay JL; Perruchoud AP; Reuter J; Bolliger C; Herrmann R; Rochlitz C
    Cancer Gene Ther; 2000 Sep; 7(9):1215-9. PubMed ID: 11023193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
    Ramondetta L; Mills GB; Burke TW; Wolf JK
    Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.